Dale R Pfost - Net Worth and Insider Trading

Dale R Pfost Net Worth

The estimated net worth of Dale R Pfost is at least $4,275 dollars as of 2024-09-20. Dale R Pfost is the CEO of Chemomab Therapeutics Ltd and owns about 2,500 shares of Chemomab Therapeutics Ltd (CMMB) stock worth over $4,275. Details can be seen in Dale R Pfost's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dale R Pfost has not made any transactions after 2022-03-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dale R Pfost

To

Dale R Pfost Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dale R Pfost owns 3 companies in total, including CalEthos Inc (GEDC) , OPKO Health Inc (OPK) , and Chemomab Therapeutics Ltd (CMMB) .

Click here to see the complete history of Dale R Pfost’s form 4 insider trades.

Insider Ownership Summary of Dale R Pfost

Ticker Comapny Transaction Date Type of Owner
GEDC CalEthos Inc 2007-04-30 director
OPK OPKO Health Inc 2007-03-29 President
CMMB Chemomab Therapeutics Ltd 2022-03-14 director & Chief Executive Officer

Dale R Pfost Latest Holdings Summary

Dale R Pfost currently owns a total of 1 stock. Dale R Pfost owns 2,500 shares of Chemomab Therapeutics Ltd (CMMB) as of March 14, 2022, with a value of $4,275.

Latest Holdings of Dale R Pfost

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CMMB Chemomab Therapeutics Ltd 2022-03-14 2,500 1.71 4,275

Holding Weightings of Dale R Pfost


Dale R Pfost Form 4 Trading Tracker

According to the SEC Form 4 filings, Dale R Pfost has made a total of 1 transactions in Chemomab Therapeutics Ltd (CMMB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Chemomab Therapeutics Ltd is the acquisition of 2,500 shares on March 14, 2022, which cost Dale R Pfost around $9,950.

Insider Trading History of Dale R Pfost

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dale R Pfost Trading Performance

GuruFocus tracks the stock performance after each of Dale R Pfost's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dale R Pfost is -16.62%. GuruFocus also compares Dale R Pfost's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dale R Pfost within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dale R Pfost's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dale R Pfost

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Dale R Pfost Ownership Network

Ownership Network List of Dale R Pfost

No Data

Ownership Network Relation of Dale R Pfost

Insider Network Chart

Dale R Pfost Owned Company Details

What does CalEthos Inc do?

Who are the key executives at CalEthos Inc?

Dale R Pfost is the director of CalEthos Inc. Other key executives at CalEthos Inc include 10 percent owner Sean Paul Fontenot , Chief Technology Officer Hyuncheol Peter Kim , and director & 10 percent owner & Chief Executive Officer Michael Campbell .

CalEthos Inc (GEDC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CalEthos Inc (GEDC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CalEthos Inc (GEDC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CalEthos Inc (GEDC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CalEthos Inc Insider Transactions

No Available Data

Dale R Pfost Mailing Address

Above is the net worth, insider trading, and ownership report for Dale R Pfost. You might contact Dale R Pfost via mailing address: Acuity Pharmaceuticals Inc, 3701 Market Street, Philadelphia Pa 19104.

Discussions on Dale R Pfost

No discussions yet.